Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Psychiatry and Psychology (18)
- Mental and Social Health (16)
- Psychiatric and Mental Health (13)
- Other Chemicals and Drugs (11)
- Medical Specialties (10)
-
- Social and Behavioral Sciences (10)
- Mental Disorders (9)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (7)
- Diseases (7)
- Life Sciences (7)
- Psychiatry (7)
- Psychology (7)
- Alternative and Complementary Medicine (6)
- Behavior and Behavior Mechanisms (6)
- Medical Sciences (6)
- Neuroscience and Neurobiology (6)
- Pharmaceutical Preparations (6)
- Other Psychiatry and Psychology (5)
- Public Health (5)
- Behavioral Neurobiology (4)
- Biology (4)
- Investigative Techniques (4)
- Nervous System Diseases (4)
- Anatomy (3)
- Biochemistry, Biophysics, and Structural Biology (3)
- Chemical and Pharmacologic Phenomena (3)
- Hormones, Hormone Substitutes, and Hormone Antagonists (3)
- Nursing (3)
- Institution
-
- Virginia Commonwealth University (5)
- Rowan University (4)
- University of Connecticut (3)
- Claremont Colleges (2)
- Edith Cowan University (2)
-
- James Madison University (2)
- Liberty University (2)
- University of Texas Rio Grande Valley (2)
- Arcadia University (1)
- Belmont University (1)
- Chapman University (1)
- City University of New York (CUNY) (1)
- Kutztown University (1)
- LSU Health New Orleans (1)
- Lesley University (1)
- Lincoln Memorial University (1)
- National Louis University (1)
- Ohio Northern University (1)
- Old Dominion University (1)
- Philadelphia College of Osteopathic Medicine (1)
- Pittsburg State University (1)
- Thomas Jefferson University (1)
- University of Nebraska - Lincoln (1)
- University of New Hampshire (1)
- University of San Diego (1)
- University of Texas at Arlington (1)
- Publication Year
- Publication
-
- Rowan-Virtua Research Day (4)
- Theses and Dissertations (4)
- Honors Scholar Theses (3)
- School of Medicine Publications (2)
- Scripps Senior Theses (2)
-
- Senior Honors Theses (2)
- Capstone Showcase (1)
- Department of Psychology: Faculty Publications (1)
- Dissertations (1)
- Dissertations, Theses, and Capstone Projects (1)
- Doctor of Nursing Practice (DNP) Scholarly Projects - Archive (1)
- Doctor of Nursing Practice Scholarly Project (1)
- English Department: Research for Change - Wicked Problems in Our World (1)
- Expressive Therapies Capstone Theses (1)
- Health Behavior, Policy & Management Faculty Publications (1)
- Honors Scholars Collaborative Projects (1)
- Honors Theses and Capstones (1)
- Master of Science in Physician Assistant Studies Capstone Presentations (Center City) (1)
- PCOM Physician Assistant Studies Student Scholarship (1)
- Pharmacy and Wellness Review (1)
- Physician Assistant Capstones, 2016 to 2019 (1)
- Physician Assistant Capstones, 2020-current (1)
- Psychology Faculty Articles and Research (1)
- Research Projects (1)
- Research outputs 2014 to 2021 (1)
- Research outputs 2022 to 2026 (1)
- School of Medicine Faculty Publications (1)
- UROP Posters (1)
- Undergraduate Honors Theses (1)
- Publication Type
- File Type
Articles 31 - 40 of 40
Full-Text Articles in Chemicals and Drugs
Music As A Catalyst For Altered States Of Consciousness And Peak Experiences In The Treatment Of Depression, Anxiety, And Ptsd, Paul Battles
Music As A Catalyst For Altered States Of Consciousness And Peak Experiences In The Treatment Of Depression, Anxiety, And Ptsd, Paul Battles
Expressive Therapies Capstone Theses
Abstract This paper investigates the therapeutic uses of altered states of consciousness (ASC) and peak experiences (PE) for the treatment of depression, anxiety, and post-traumatic stress disorder (PTSD), and the ways in which music can be used to facilitate or enhance these experiences. ASC’s and PE’s can help uncover hidden or repressed unconscious material and potentially change the way an individual views and interacts with his or her world. In cases of people suffering from depression, anxiety, and post-traumatic stress disorder (PTSD), these emotional, cognitive, and perceptual changes have been shown to have sometimes profound and long- lasting therapeutic effects, …
Determining The Knowledge, Attitudes And Beliefs Of Healthcare Providers In Treating Non-Specific Acute And Chronic Back Pain, Stacey L. Kale
Determining The Knowledge, Attitudes And Beliefs Of Healthcare Providers In Treating Non-Specific Acute And Chronic Back Pain, Stacey L. Kale
Doctor of Nursing Practice Scholarly Project
An Abstract of the Scholarly Project by
Stacey Kale
Managing back pain has become a public health and clinical challenge (Krein et al., 2016). Incidence of back pain related complaints requiring treatment in the US is estimated at 11.2% of the adult population (Dowell, Haegerich, & Chou, 2016). New research suggests that it is the most common pain problem (Pauline, 2016). It is the third most expensive health disorder and is exceeded only by cancer and heart disease. Many health care providers lack formal pain management education and training thus leaving them at risk for failing to properly manage patients …
The Effects Of Testosterone Supplementation On Cognitive Functioning In Older Men, Eka Wahjoepramono, Prita Asih, Vilia Aniwiyanti, Kevin Taddei, Satvinder Dhaliwal, Stephanie Fuller, Jonathan Foster, Malcolm Carruthers, Giuseppe Verdile, Hamid R. Sohrabi, Ralph Martins
The Effects Of Testosterone Supplementation On Cognitive Functioning In Older Men, Eka Wahjoepramono, Prita Asih, Vilia Aniwiyanti, Kevin Taddei, Satvinder Dhaliwal, Stephanie Fuller, Jonathan Foster, Malcolm Carruthers, Giuseppe Verdile, Hamid R. Sohrabi, Ralph Martins
Research outputs 2014 to 2021
Reduction in testosterone levels in men during aging is associated with cognitive decline and risk of dementia. Animal studies have shown benefits for testosterone supplementation in improving cognition and reducing Alzheimer’s disease pathology. In a randomized, placebo-controlled, crossover study of men with subjective memory complaint and low testosterone levels, we investigated whether testosterone treatment significantly improved performance on various measures of cognitive functioning. Forty-four men were administered a battery of neuropsychological tests to establish the baseline prior to being randomly divided into two groups. The first group (Group A) received 24 weeks of testosterone treatment (T treatment) followed by 4 …
Ketamine, A Brighter Future For Those In Darkness, Matthew D. Gayhart
Ketamine, A Brighter Future For Those In Darkness, Matthew D. Gayhart
UROP Posters
Millions of people around the world suffer from Major Depressive Disorder, and many of these people are given drugs to help treat this potentially devastating disease. For many, the first treatment is successful, and if not, certainly the second treatment gives them the relief they so desperately need. Others, however, are not so lucky, people with treatment resistant depression undergo numerous treatments, some of which are more aggressive than others, but still nothing helps alleviate their depression. Recently an older anesthetic, the drug Ketamine, has been making some news as a new depression treatment. This paper will compare Ketamine to …
Chronic Behavioral And Cognitive Deficits In A Rat Survival Model Of Organophosphate Toxicity, Beverly Huang
Chronic Behavioral And Cognitive Deficits In A Rat Survival Model Of Organophosphate Toxicity, Beverly Huang
Theses and Dissertations
Organophosphates (OPs) are a major class of pesticides and nerve agents that elicit acute toxicity by inhibiting acetylcholinesterase (AChE), the enzyme responsible for the degradation of the neurotransmitter acetylcholine in the central and peripheral nervous systems. Acetylcholine accumulation following extensive AChE inhibition leads to an acute cholinergic syndrome characterized by autonomic dysfunction, involuntary movements, muscle fasciculations, respiratory distress, and seizures. Despite their classification as moderate to highly toxic, OP pesticides are the most widely used class of insecticides in the U.S., and are even more commonly used worldwide. Additionally, there is a growing concern that OP nerve agents could be …
The Reversal Effects Of Curcumin, An Herbal Remedy, On The Impairments Induced By Vmat-2 Inhibitor Tetrabenazine, Emily Qian, Samantha E. Yohn
The Reversal Effects Of Curcumin, An Herbal Remedy, On The Impairments Induced By Vmat-2 Inhibitor Tetrabenazine, Emily Qian, Samantha E. Yohn
Honors Scholar Theses
Substantial evidence has shown that dopamine (DA), particularly in the nucleus accumbens (NAc), is involved in behavioral activation and effort-related processes, such as overcoming work related response costs. Interference with accumbens DA transmission through administration of the vesicular monoamine transportor-2 (VMAT-2) inhibitor tetrabenazine (TBZ) produces an alteration of response allocation in the concurrent FR5/chow choice procedure, biasing animals toward the lower effort alternative. It has been suggested that these drug-induced shifts in effort-related choice behavior seen in rodents are analogous to symptoms such as psychomotor retardation, anergia, and fatigue, which can be observed in people with depression and other related …
Norepinephrine Involvement In The Intermittent Swim Stress-Induced Deficit In Spatial Learning And Memory, Emily Elgert
Norepinephrine Involvement In The Intermittent Swim Stress-Induced Deficit In Spatial Learning And Memory, Emily Elgert
Honors Theses and Capstones
Learning and memory impairments are often caused by stress disorders including depression. The present study investigated the involvement of norepinephrine in the swim stress-induced deficits of spatial learning and memory. Exposure to intermittent swim stress (ISS) followed by learning and memory tests in the Morris water maze (MWM) were used to investigate this relationship. The ISS paradigm consists of intermittent exposure to cold water, producing stress responses in rats. Reboxetine, a norepinephrine selective reuptake inhibitor (NSRI), was employed to investigate whether this compound reverses the ISS-induced deficit. In other words, rats exposed to the ISS, were hypothesized to experience impaired …
Drug–Drug Conditioning Between Citalopram And Haloperidol Or Olanzapine In A Conditioned Avoidance Response Model: Implications For Polypharmacy In Schizophrenia, Nathan L. Sparkman, Ming Li
Drug–Drug Conditioning Between Citalopram And Haloperidol Or Olanzapine In A Conditioned Avoidance Response Model: Implications For Polypharmacy In Schizophrenia, Nathan L. Sparkman, Ming Li
Department of Psychology: Faculty Publications
Patients with schizophrenia often have anxiety and depression, and thus are treated with multiple psychotherapeutic medications. This practice of polypharmacy increases the possibility for drug–drug interactions. However, the pharmacological and behavioral mechanisms underlying drug–drug interactions in schizophrenia remain poorly understood. In the present study, we adopted a preclinical approach and examined a less known behavioral mechanism, drug–drug conditioning (DDC) between haloperidol (a typical antipsychotic) or olanzapine (atypical antipsychotic) and citalopram (a selective serotonin reuptake inhibitor). A rat two-way conditioned avoidance response paradigm was used to measure antipsychotic activity and determine how DDC may alter the antipsychotic efficacy in this model. …
Does Fish Oil Supplementation (Omega-3 Pufa) Cause Mood Improvement In Adults With Depression, Lauren Cabana
Does Fish Oil Supplementation (Omega-3 Pufa) Cause Mood Improvement In Adults With Depression, Lauren Cabana
PCOM Physician Assistant Studies Student Scholarship
Objective: The objective of this systematic review is to determine whether or not “Does fish oil supplementation (omega-3 PUFA) cause mood improvement in adults with depression?”
Novel Analogs Of M-Chlorophenylguanidine As 5-Ht3 Receptor Ligands, Katie Alix
Novel Analogs Of M-Chlorophenylguanidine As 5-Ht3 Receptor Ligands, Katie Alix
Theses and Dissertations
Serotonin receptors play a variety of functional roles in the body. Some indications and treatment claims for one of the classes of serotonin receptors, the 5-HT3 receptor family, include: anxiety, depression, chemotherapy- and radiation-induced emesis, constipation, irritable bowel syndrome, pain, drug addiction, and satiety control. A 5-HT3 receptor partial agonist, MD-354, served as a lead compound in the development of new 5-HT3 receptor ligands. Using halogenated analogs the study investigated their effect on binding to the 5-HT3 receptor. Conformationally-constrained analogs (quinazolines) were shown to be a novel class of 5-HT3 receptor antagonists. The log P values were determined for several …